C12N 2710/00032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/00032 (Use of virus as therapeutic agent, other than vaccine) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 26 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Host bacterium specific nanoparticle24 Feb 2022US 2022/0056474 A1National University Corporation Tokai National Higher Education and Research System
- Anti-angiogenic adenovirus21 May 2020US 2020/0155625 A1EpicentRx, Inc.
- Multilamellar lipid vesicle compositions and methods of use31 Aug 2017US 2017/0246288 A1Vedantra Pharmaceuticals, Inc.
- Method for determining sensitivity to a bacteriophage2 Jun 2005US 2005/0118567 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.